← All Pure Bioscience, INC filings

Pure Bioscience, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OQB
PURE
Pure Bioscience, INC
Form 4: Pure Bioscience Exec VP Acquires 155,000 Stock Options
Thomas Myers, Exec VP of Tech & Development at Pure Bioscience, acquired 155,000 stock options on August 20, 2024.
OQB
PURE
Pure Bioscience, INC
Form 4: Pure Bioscience Director David Rendall Acquires Stock Options
Director David Rendall reports acquisition of stock options in Pure Bioscience, Inc.
OQB
PURE
Pure Bioscience, INC
Form 4: PURE Bioscience Director Acquires Stock Options
Director Bernard Blotner acquired stock options in PURE Bioscience, Inc. on August 20, 2024.
OQB
PURE
Pure Bioscience, INC
Form 4: Pure Bioscience VP of Finance Acquires Stock Options
Mark Stuart Elliott, Vice President of Finance at Pure Bioscience, acquired stock options for 155,000 shares at an exercise price of $0.07 on August 20, 2024.
OQB
PURE
Pure Bioscience, INC
Form 4: Tom Y. Lee Acquires Stock Options in PURE Bioscience, Inc.
Director Tom Y. Lee acquired stock options in PURE Bioscience, Inc. on August 20, 2024.
OQB
PURE
Pure Bioscience, INC
Form 4: Pure Bioscience CEO Acquires Options in Company Stock
Robert Bartlett, CEO and President of Pure Bioscience, acquired options to purchase company stock on August 20, 2024.
OQB
PURE
Pure Bioscience, INC
Form 4: Pure Bioscience Director Acquires Stock Options
Director Ivan Chen acquired stock options in Pure Bioscience, Inc.
OQB
PURE
Pure Bioscience, INC
Form 4: PURE Bioscience Director Darin Zehr Acquires Stock Options
Director Darin Zehr acquired stock options in PURE Bioscience, Inc. on August 20, 2024.